Myomatous erythrocytosis syndrome

From WikiMD.org
Jump to navigation Jump to search

Myomatous Erythrocytosis Syndrome (pronunciation: my-o-ma-tous er-y-thro-cy-to-sis syn-drome) is a rare medical condition characterized by the presence of a uterine fibroid that secretes erythropoietin, leading to erythrocytosis.

Etymology

The term "Myomatous Erythrocytosis Syndrome" is derived from the words "myoma" (a type of tumor that develops from muscle tissue), "erythrocytosis" (an abnormal increase in the number of red blood cells), and "syndrome" (a group of symptoms that consistently occur together).

Symptoms

Patients with Myomatous Erythrocytosis Syndrome typically present with symptoms of erythrocytosis such as fatigue, headaches, and dizziness. They may also have symptoms related to the presence of a uterine fibroid, such as heavy menstrual bleeding, pelvic pain, and frequent urination.

Diagnosis

Diagnosis of Myomatous Erythrocytosis Syndrome involves a combination of blood tests to detect erythrocytosis, imaging studies to identify the presence of a uterine fibroid, and sometimes, a biopsy of the fibroid to confirm that it is secreting erythropoietin.

Treatment

Treatment for Myomatous Erythrocytosis Syndrome typically involves addressing the underlying uterine fibroid. This can be done through surgical removal of the fibroid, or through medical therapies that aim to shrink the fibroid. In some cases, treatment may also involve measures to manage the symptoms of erythrocytosis.

Related Terms

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski